Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eucrisa in Seborrheic Dermatitis
NCT03567980Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Sep 2018
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of AN2728 ointment vehicle in seborrheic dermatitis (SD), sponsored by University of Alabama at Birmingham. Primary endpoint: Investigator's Static Global Assessment at 4 weeks. Started Sep 2018; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT03567980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03567980.